相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
R. A. Wilke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
Chun-Yu Wei et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Statins Personalized
H. Robert Superko et al.
MEDICAL CLINICS OF NORTH AMERICA (2012)
Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation
Frank S. Ong et al.
PHARMACOGENOMICS (2012)
Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy
A. Savonarola et al.
PHARMACOGENOMICS JOURNAL (2012)
Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II Alleles
M. Isabel Lucena et al.
GASTROENTEROLOGY (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study
Luca Puccetti et al.
ATHEROSCLEROSIS (2010)
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
Nita A. Limdi et al.
BLOOD (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Jonathan B. Singer et al.
NATURE GENETICS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis
Sae-Hoon Kim et al.
PHARMACOGENOMICS (2010)
The SLCO1B1*5 Genetic Variant Is Associated With Statin-Induced Side Effects
Deepak Voora et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
Ann K. Daly et al.
NATURE GENETICS (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients
Soranun Chantarangsu et al.
PHARMACOGENETICS AND GENOMICS (2009)
APOE gene polymorphisms and response to statin therapy
E. Zintzaras et al.
PHARMACOGENOMICS JOURNAL (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective
Shashi Amur et al.
BIOMARKERS IN MEDICINE (2008)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Pharmacogenetic Predictors of Statin-Mediated Low-Density Lipoprotein Cholesterol Reduction and Dose Response
Deepak Voora et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2008)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
Pharmacogenetics of apolipoprtein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease
Tuomo Nieminen et al.
PHARMACOGENOMICS (2008)
HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis
Nahoko Kaniwa et al.
PHARMACOGENOMICS (2008)
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A. Kindmark et al.
PHARMACOGENOMICS JOURNAL (2008)
HLA-B*1502-bound peptides: Implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome
Chih-Wen Ou Yang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens
M. Dettling et al.
PHARMACOGENOMICS JOURNAL (2007)
HLA-Cw8 primarily associated with hypersensitivity to nevirapine
Hiroyuki Gatanaga et al.
AIDS (2007)
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
George Cusatis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients
Roberto Littera et al.
AIDS (2006)
Genetic mechanism of aspirin-induced urticaria/angioedema
Seung-Hyun Kim et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions
Shuen-Lu Hung et al.
PHARMACOGENETICS AND GENOMICS (2006)
Pharmacogenomics of human OATP transporters
J König et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets
J Kirchheiner et al.
PHARMACOGENETICS AND GENOMICS (2005)
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
HY Yuan et al.
HUMAN MOLECULAR GENETICS (2005)
Priorities and standards in pharmacogenetic research
AC Need et al.
NATURE GENETICS (2005)
ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation
IA Hauser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
SL Hung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria
SH Kim et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts
AM Martin et al.
AIDS (2005)
Pharmacogenetics of antidepressants and antipsychotics:: the contribution of allelic variations to the phenotype of drug response
J Kirchheiner et al.
MOLECULAR PSYCHIATRY (2004)
Adverse drug reactions: role of pharmacogenomics
G Severino et al.
PHARMACOLOGICAL RESEARCH (2004)
Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations
AR Hughes et al.
PHARMACOGENOMICS (2004)
Pharmacogenetics - five decades of therapeutic lessons from genetic diversity
UA Meyer
NATURE REVIEWS GENETICS (2004)
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
E Schaeffeler et al.
PHARMACOGENETICS (2004)
Achieving greater reductions in cardiovascular risk: Lessons from statin therapy on risk measures and risk reduction
CM Ballantyne
AMERICAN HEART JOURNAL (2004)
Pharmacogenetic study of statin therapy and cholesterol reduction
DI Chasman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells
A Nassif et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
S Mallal et al.
LANCET (2002)
Genetic susceptibility to adverse drug reactions
M Pirmohamed et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Pharmacogenetics of warfarin elimination and its clinical implications
H Takahashi et al.
CLINICAL PHARMACOKINETICS (2001)
分享论文
